NU 98X3: IRINOTECAN (CPT-11) AND GEMCITABINE IN PATIENTS WITH SOLID TUMORS
NU 98X3: IRINOTECAN (CPT-11) AND GEMCITABINE IN PATIENTS WITH SOLID TUMORS
批准号:
7604237
负责人:
AL B BENSON
金额:
$0.59万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30
中文摘要
该子项目是利用
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得主要资金,
因此可以在其他CRISP条目中表示。列出的机构是
中心,不一定是研究者的机构。
本研究涉及两种静脉化疗药物治疗:伊立替康(CPT-11)和吉西他滨。 虽然这两种药物已分别用于治疗各种癌症,但当它们一起使用时,最佳剂量和时间表尚未确定。 本研究的目的是发现CPT-11与吉西他滨联合给药时安全的最高剂量。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
This study involves treatment with two intravenous chemotherapy drugs: Irinotecan (CPT-11) and Gemcitabine. While both drugs have been utilized separately for the treatment of a wide variety of cancers, the best dose and schedule has yet to be determined when using them together. The purpose of this study is to discover the highest dose of CPT-11 that can be given safely with Gemcitabine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making
-
批准号:10797946
-
项目类别:
-
资助金额:$222.45万
-
财政年份:2023
-
负责人:AL B BENSON
-
依托单位:
Northwestern University Lead Academic Participating Site, GY4 Supplemental Request
-
批准号:10736415
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2022
-
负责人:AL B BENSON
-
依托单位:
Northwestern University Lead Academic Participating Site
-
批准号:10357915
-
项目类别:
-
资助金额:$51.52万
-
财政年份:2019
-
负责人:AL B BENSON
-
依托单位:
Northwestern University Lead Academic Participating Site
-
批准号:10583453
-
项目类别:
-
资助金额:$77.52万
-
财政年份:2019
-
负责人:AL B BENSON
-
依托单位:
Northwestern University Lead Academic Participating Site
-
批准号:9901493
-
项目类别:
-
资助金额:$51.52万
-
财政年份:2019
-
负责人:AL B BENSON
-
依托单位:
Northwestern University Lead Academic Participating Site Supplement Year 2
-
批准号:10299729
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2019
-
负责人:AL B BENSON
-
依托单位:
Northwestern University Lead Academic Participating Site
-
批准号:10062109
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2019
-
负责人:AL B BENSON
-
依托单位:
NU 98X3: IRINOTECAN (CPT-11) AND GEMCITABINE IN PATIENTS WITH SOLID TUMORS
-
批准号:7200422
-
项目类别:
-
资助金额:$0.41万
-
财政年份:2004
-
负责人:AL B BENSON
-
依托单位:
NU 98X3: Irinotecan (CPT-11) and Gemcitabine in Patients with Solid Tumors
-
批准号:7040344
-
项目类别:
-
资助金额:$0.59万
-
财政年份:2003
-
负责人:AL B BENSON
-
依托单位:
CORE--CLINICAL RESEARCH OFFICE
-
批准号:6396860
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1999
-
负责人:AL B BENSON
-
依托单位:
CORE--CLINICAL RESEARCH OFFICE
-
批准号:6395751
-
项目类别:
-
资助金额:$0.13万
-
财政年份:1999
-
负责人:AL B BENSON
-
依托单位:
CORE--CLINICAL RESEARCH OFFICE
-
批准号:6269629
-
项目类别:
-
资助金额:$14.0万
-
财政年份:1998
-
负责人:AL B BENSON
-
依托单位:
CORE--CLINICAL RESEARCH OFFICE
-
批准号:6102938
-
项目类别:
-
资助金额:$0.13万
-
财政年份:1998
-
负责人:AL B BENSON
-
依托单位:
Protocol Review and Monitoring System
-
批准号:10902202
-
项目类别:
-
资助金额:$17.2万
-
财政年份:1997
-
负责人:AL B BENSON
-
依托单位:
Protocol Review and Monitoring System
-
批准号:10228213
-
项目类别:
-
资助金额:$23.44万
-
财政年份:1997
-
负责人:AL B BENSON
-
依托单位:
Protocol Review and Monitoring System
-
批准号:10460220
-
项目类别:
-
资助金额:$23.44万
-
财政年份:1997
-
负责人:AL B BENSON
-
依托单位:
CORE--CLINICAL RESEARCH OFFICE
-
批准号:6237432
-
项目类别:
-
资助金额:$13.33万
-
财政年份:1997
-
负责人:AL B BENSON
-
依托单位:
THYMIDYLATE SYNTHASE EXPRESSION IN COLORECTAL CANCER
-
批准号:2110756
-
项目类别:
-
资助金额:$15.34万
-
财政年份:1995
-
负责人:AL B BENSON
-
依托单位:
THYMIDYLATE SYNTHASE EXPRESSION IN COLORECTAL CANCER
-
批准号:2110757
-
项目类别:
-
资助金额:$15.74万
-
财政年份:1995
-
负责人:AL B BENSON
-
依托单位:
PHASE I AND PHARMACOKINETIC STUDIES OF OLTIPRAZ
-
批准号:3622066
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1989
-
负责人:AL B BENSON
-
依托单位:
海外基金